Notice: This company has been marked as potentially delisted and may not be actively trading. Turning Point Therapeutics (TPTX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Turning Point of Tampa Now In-Network with Blue Cross Blue Shield InsuranceSeptember 29, 2024 | markets.businessinsider.comPTC Therapeutics, Inc. (PTCT) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comTG Therapeutics, Inc. (TGTX) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | seekingalpha.comViking Therapeutics, Inc. (VKTX) Q2 2024 Earnings Call TranscriptJuly 25, 2024 | seekingalpha.comTurning Point Brands Inc.February 17, 2024 | wsj.comAlzheimer’s: A Turning Point?February 12, 2024 | bbc.co.ukTurning Point Brands Inc (TPB)February 10, 2024 | investing.comCormorant Asset Management, LP's Net WorthFebruary 10, 2024 | benzinga.comSolving quadratic equations - EdexcelJanuary 15, 2024 | bbc.co.ukCOP15: A Turning Point for Investor Approaches to BiodiversityDecember 19, 2023 | morningstar.comTurning Point USA: Are conservatives fighting back on campus?December 16, 2023 | bbc.comTattoos have reached a turning point at workJuly 29, 2023 | ft.comTurning Point USAJuly 11, 2023 | newsweek.comTurning Point HospitalJune 23, 2023 | health.usnews.comCan Vinicius episode be a turning point in football’s racism battle?June 5, 2023 | bbc.co.ukTurning Point Secondary SchoolMay 24, 2023 | usnews.com2023 could be turning point for office-to-housing conversions: ColliersApril 12, 2023 | ca.finance.yahoo.comThe invasion of Iraq was a turning point on to a path that led towards UkraineMarch 22, 2023 | theguardian.comPutin's arrest warrant is turning point – ZelenskyyMarch 22, 2023 | news.yahoo.comZelenskyy: Putin's arrest warrant marks 'turning point,' he’ll be held responsible for 'every destroyed life'March 22, 2023 | foxnews.com'Deposit return scheme can be turning point in litter battle'March 21, 2023 | uk.news.yahoo.com2023 may be turning point in impact of sanctions on RussiaMarch 21, 2023 | news.yahoo.comTurning Point Ministries Welcomes New Chief Development OfficerMarch 19, 2023 | benzinga.com1 Stock to Buy This Week and Hold for the Next 20 YearsMarch 14, 2023 | stocknews.comHarry and Meghan's 'whining' Netflix series was 'turning point' with US, says authorMarch 8, 2023 | mirror.co.ukWhy 2023 might just be a turning point for climate actionMarch 1, 2023 | ft.comBruno Fernandes outlines Man Utd turning point after "really bad" momentFebruary 26, 2023 | mirror.co.ukTurning Point Brands raises dividend by 8% to $0.065February 25, 2023 | seekingalpha.comThese 4 major new Indian military inductions mark a positive turning pointFebruary 19, 2023 | msn.comIs this Australia’s turning point for concussion in sport?February 17, 2023 | theguardian.comFBI Investigation Into Donald Trump Reaches 'Big Turning Point'February 17, 2023 | newsweek.comCadrenal Therapeutics Hit Lowest Point Since Friday IPO, Down 21%January 27, 2023 | marketwatch.comGermany Agrees To Send Leopard 2 Tanks To Ukraine: Could This Be A Turning Point For The War?January 26, 2023 | benzinga.comBristol Myers Squibb To Acquire Turning Point TherapeuticsJanuary 26, 2023 | finanznachrichten.deTurning point? Softer US inflation prompts more to dump the DollarJanuary 17, 2023 | fxstreet.comBiden’s summit with Japanese leader marks a turning pointJanuary 15, 2023 | washingtonpost.comMSNBC edits column after Turning Point USA sends cease-and-desist letter blasting 'defamatory' commentJanuary 15, 2023 | foxnews.comHandicapping whether the stock market is at a turning point after Thursday's upside reversalOctober 17, 2022 | cnbc.comThe Energy Report: Turning PointOctober 7, 2022 | investing.comThe Ukraine war has reached a turning pointSeptember 21, 2022 | ft.comTurning Point Therapeutics, Inc. (NASDAQ:TPTX) Given Average Rating of "Hold" by BrokeragesTurning Point Therapeutics, Inc. (NASDAQ:TPTX - Get Rating) has received an average rating of "Hold" from the twelve brokerages that are covering the stock, Marketbeat reports. Eight research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. TheSeptember 19, 2022 | marketbeat.comTrading was temporarily halted for "TPTX" at 07:08 PM with a stated reason of "News pending."August 17, 2022 | marketbeat.comTurning Point Therapeutics (NASDAQ:TPTX) Releases Quarterly Earnings Results, Misses Estimates By $0.78 EPSTurning Point Therapeutics (NASDAQ:TPTX - Get Rating) announced its quarterly earnings results on Monday. The company reported ($2.48) earnings per share for the quarter, missing the consensus estimate of ($1.70) by ($0.78). The business had revenue of $0.12 million for the quarter, compared to analyst estimates of $2.27 million. The firm's revenue for the quarter was down 97.7% compared to the same quarter last year. During the same period in the prior year, the firm earned ($1.14) earnings per share.August 9, 2022 | marketbeat.comTurning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational UpdatesAugust 8, 2022 | finance.yahoo.comShort Interest in Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Drops By 25.5%Turning Point Therapeutics, Inc. (NASDAQ:TPTX - Get Rating) was the recipient of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 2,130,000 shares, a decline of 25.5% from the June 30th total of 2,860,000 shares. Currently, 5.0% of the shares of the company are sold short. Based on an average trading volume of 1,830,000 shares, the short-interest ratio is presently 1.2 days.August 3, 2022 | marketbeat.comTurning Point Therapeutics, Inc. (NASDAQ:TPTX) Receives Consensus Recommendation of "Hold" from BrokeragesShares of Turning Point Therapeutics, Inc. (NASDAQ:TPTX - Get Rating) have been assigned a consensus rating of "Hold" from the twelve brokerages that are currently covering the stock, Marketbeat reports. Eight investment analysts have rated the stock with a hold rating and three have assigned a buJuly 31, 2022 | marketbeat.comTurning Point Therapeutics, Inc. (NASDAQ:TPTX) CFO Paolo Tombesi Sells 1,183 SharesTurning Point Therapeutics, Inc. (NASDAQ:TPTX - Get Rating) CFO Paolo Tombesi sold 1,183 shares of the firm's stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $74.94, for a total transaction of $88,654.02. Following the completion of the sale, the chief financial officer now owns 28,700 shares of the company's stock, valued at $2,150,778. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.July 29, 2022 | marketbeat.comTurning Point Secures Positive FDA Feedback For Planned Lung Cancer Drug SubmissionJuly 27, 2022 | msn.comTurning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLCJuly 27, 2022 | finance.yahoo.comBristol-Myers (BMY) to Post Q2 Earnings: What is in the Cards?July 25, 2022 | finance.yahoo.com Get Turning Point Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TPTX and its competitors with MarketBeat's FREE daily newsletter. Email Address This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here TPTX Media Mentions By Week TPTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TPTX News Sentiment▼0.800.46▲Average Medical News Sentiment TPTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TPTX Articles This Week▼00▲TPTX Articles Average Week Get Turning Point Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TPTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Schrödinger News Emergent BioSolutions News Sage Therapeutics News Allakos News Summit Therapeutics News Genmab A/S News Insmed News BioMarin Pharmaceutical News Dr. Reddy's Laboratories News Catalent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TPTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turning Point Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turning Point Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
